Succeed Against Difficult Targets with the Opto® Plasma B Discovery Workflow on the Beacon® System
Discover how the Opto® Plasma B Discovery on the Beacon optofluidic system allows Pharma to succeed against difficult targets and deliver best-in-class antibody therapeutics.
What's Inside
In this Brochure we discuss:
Target to lead molecule in weeks, not months.
Expand your pipeline and maximize revenue.
Access to greater diversity delivers antibodies against the most difficult targets.
Increase the probability of campaign success with the industry’s premier antibody discovery platform.
